Here at OutsourcingPharma, we put our audience at the heart of what we do. For many years, we have provided our readers with a 360-degree view of the pharma landscape and our editorial standards remain unsurpassed.
The top three myths of ‘going digital’ relate to the industry’s self-image, the perceived role of technology, and current market conditions – still, digital is not a fad and is here to stay, says industry expert.
With increasing pressures on pharma pipelines leading to greater
interest in compound licensing, firms can be caught out by failing
to give scalability issues due attention, according to Joseph
D'Antuono speaking at last week's...